Enbezotinib
Enbezotinib, an inhibitor of RET, can inhibit the RET autophosphorylation. Enbezotinib can be used for the research of cancer[1].
Product Specifications
CAS Number
[2359649-81-1]
Product Name Alternative
TPX-0046
UNSPSC
12352005
Target
RET
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/enbezotinib.html
Purity
99.50
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 80°C)
Smiles
FC(C=C1CN2C3=NC4=C5C=NN4C=C3O[C@]6([H])[C@@]2([H])CCC6)=CN=C1O[C@@H](C)CNC5=O
Molecular Formula
C21H21FN6O3
Molecular Weight
424.43
References & Citations
[1]ROGERS EW, et, al. Macrocyclic compounds for treating disease. WO2019126121A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6470133-01 0.2 mL
Connexin 37, CT (Gap Junction alpha-4 Protein, GJA4, Connexin-37, Cx37) (PE)
Ask
View Details MBS6470133-02 5x 0.2 mL
Connexin 37, CT (Gap Junction alpha-4 Protein, GJA4, Connexin-37, Cx37) (PE)
Ask
View Details 